85
Views
2
CrossRef citations to date
0
Altmetric
Drug Profile

Pharmacology, clinical efficacy and safety of olopatadine hydrochloride

&
Pages 341-351 | Published online: 10 Jan 2014
 

Abstract

Olopatadine is a multimechanism anti-allergic agent that inhibits H1 receptor activation and stabilizes mast cell membranes, blocking the release of allergic and inflammatory mediators. Studies in human conjunctival mast cells clearly demonstrate, in the relevant tissue and species, olopatadine’s inhibition of histamine release, which was subsequently confirmed in allergen-challenged subjects. Its comfort and tolerability may be related to the absence of perturbation of cell membranes, in contrast to many anti-allergics, whose disruption of membranes lead to histamine release even at therapeutically relevant concentrations. In preclinical and clinical studies, olopatadine had greater efficacy and comfort than other anti-allergic agents available today for ophthalmic use.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 718.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.